I
nnate immune mechanisms represent the first line of defense against invading pathogens, limiting acute infection as well as triggering and directing the adaptive response. NK cells can play a crucial role in the innate response to infection by lysis of infected cells and by secretion of proinflammatory cytokines, such as IFN-␥, that promote phagocytic clearance of microbes and guide T cell differentiation (1, 2) . In contrast, dysregulated innate inflammatory responses may predispose to onset of immune-mediated pathology (3) (4) (5) . Knowledge of the mechanisms of induction and regulation of the NK IFN-␥ response may aid our understanding of the immunopathological basis of disease, identify novel adjuvant strategies for immunization or new targets for immunotherapy, and inform approaches for controlling unwanted inflammation.
NK cell activity is regulated by an extensive repertoire of regulatory receptors, which may be constitutively expressed or upregulated upon activation and which bind to constitutively expressed or stress-induced self-ligands (6) . The most polymorphic of these receptors belong to the killer Ig-like receptor (KIR) 6 family (7) , and a number of studies implicate KIR diversity (and concomitant diversity among their MHC class I ligands) in susceptibility to both infectious and noninfectious diseases (7, 8) . These studies have primarily been interpreted in the context of the "missing-self" model of NK activation (9) in which down-regulation of MHC class I on diseased cells leads to their lysis by NK cells. However, many different classes of pathogens (bacteria, protozoa, fungi, and helminths as well as viruses) are able to activate NK cells; down-regulation of MHC class I on host cells is not a consistent feature of many of these infections and in these cases NK cells are triggered by a mixture of agonist signals from myeloid or lymphoid accessory cells, including dendritic cells and monocytemacrophages (2). It is not known whether classical NK inhibitory and activating receptors play any role in regulating this indirect pathway of NK activation.
Human NK cells can be divided into two subsets according to their levels of expression of the adhesion molecule CD56 (NCAM-1) (10) . CD56 dim NK cells account for ϳ80% of NK cells in peripheral blood with CD56 bright NK cells making up the remainder. Whether these subsets represent different maturational stages of NK cells or are terminally differentiated populations remains controversial (11) (12) (13) . It has been widely assumed that the primary role of each of these subsets differs, with CD56 dim cells (which express varying combinations of the many different, highly polymorphic, KIR genes) being the major cytotoxic population and CD56 bright cells (which express only the relatively nonpolymorphic KIR2DL4 (14) ) being the major source of cytokines (10, 15) . If true, this would imply that cytokine responses of NK cells are relatively impervious to regulation by KIR-MHC interactions because the major producers of these cytokines would not express any highly polymorphic KIR. However, in apparent contradiction of this hypothesis, we have documented extensive heterogeneity of the NK cytokine response to Plasmodium falciparum (malaria)-infected RBC (iRBC) (16, 17) and in a small genetic association study have found evidence that this might be influenced by KIR genotype (16, 17) .
Here we have analyzed the human NK cell IFN-␥ response to an assortment of microbial ligands and to mononuclear cellderived cytokines. Contrary to the prevailing view, we find that both CD56 dim and CD56 bright NK cells can produce copious amounts of IFN-␥ and that, given the overwhelming preponderance of CD56 dim cells in the circulation, the vast majority of peripheral blood IFN-␥-producing NK cells are CD56 dim and KIR ϩ . Nevertheless, in many individuals, the proportion of CD56 dim NK cells producing IFN-␥ is markedly (and consistently) lower than the proportion of CD56 bright NK cells producing IFN-␥, suggesting that CD56 dim NK cells may be being regulated by KIR-MHC interactions. In support of this hypothesis, we find that the degree of inhibition of the CD56 dim NK cell population is strongly associated with KIR genotype with CD56 dim NK cells from individuals homozygous for the KIR "A" haplotype being significantly more inhibited than those of individuals with the KIR AB genotype. These data offer compelling evidence that genetic diversity within the KIR locus can moderate the NK response to a diverse array of microbial pathogens and thus suggest that KIR diversity may influence susceptibility to many different infections.
Materials and Methods

Blood donors
Healthy adult blood donors were recruited at the London School of Hygiene and Tropical Medicine through an anonymous blood donation system. All donors gave fully informed, written consent for their blood to be used in this study. Ethical approval was given by the London School of Hygiene and Tropical Medicine Ethics Committee (application no. 805).
PBMC preparation and cell culture
Venous blood was collected into sodium heparin (10 IU/ml blood; CP Pharmaceuticals) and PBMC were isolated by Histopaque 1077 (SigmaAldrich) density gradient centrifugation as previously described (17) . Cells were resuspended at a concentration of 10 6 cells/ml in RPMI 1640 containing 10% autologous serum, 100 U/ml penicillin, 100 g/ml streptomycin, and 2 mM L-glutamine (all Life Technologies) and cultured in flatbottom 24-well plates for 24 h.
HLA class I-deficient 721.221 cells (18) or 721.221 cells stably transfected with HLA-Cw6-GFP constructs (6.2 and 6.4) (19, 20) provided by D. Davis (Imperial College, London, U.K.) were cultured in RPMI 1640 medium supplemented with 10% heat-inactivated FBS, 2 mM L-glutamine, 50 U/ml penicillin/streptomycin, 1X nonessential amino acids, 1 mM sodium pyruvate, and 0.5 mM 2-ME (Invitrogen). Cultures of 721.221 HLACw6-GFP transfectants were supplemented with 1.6 mg/ml gentamicin (Life Technologies). Before use, expression of HLA class I was confirmed by staining with an anti-HLA class I Ab (W6/32).
NK cell purification and depletion of KIR-or NKG2A-positive cells
CD56
ϩ CD3 Ϫ NK cells were enriched from PBMC by magnetic cell separation (NK Cell Enrichment kit; StemCell Technologies) according to the manufacturer's instructions and using LD magnetic separation columns (Miltenyi Biotec). B cells, T cells, monocytes, and erythrocytes were retained in the column, and the effluent containing unlabelled NK cells was collected. NK cells were counted, tested for viability by trypan blue exclusion, and tested for purity by flow cytometry. Only preparations containing Ͼ95% NK cells were used.
PBMC were stained for KIR expression using the following cocktail of PE-conjugated mAbs: DX9 (KIR3DL1), DX27 (KIR2DL3, KIR2DL2 and KIR2DS2) (BD Bioscience) Z27 (KIR3DL1) and EB6 (KIR2DL1 and KIR2DS1) (Immunotech). PBMC were stained for NKG2A using a PEconjugated mAb clone Z199 (Beckman Coulter). Cells were subsequently stained with goat anti-PE MicroBeads (Miltenyi Biotec) and depletions conducted using LD columns (Miltenyi Biotec) according to the manufacturer's instructions.
Ag preparations
P. falciparum parasites (strain 3D7) were grown in O RhϪ human erythrocytes (National Blood Service, London, U.K.) in RPMI 1640 (Life Technologies) supplemented with 25 mM HEPES (Sigma-Aldrich), 28 mM sodium bicarbonate (BDH), 20 g/L hypoxanthine (Sigma-Aldrich) and 10% normal human AB serum (National Blood Service). Cultures were gassed with 3% O 2 , 4% CO 2 , and 93% N 2 and incubated at 37°C. Parasite cultures were routinely shown to be free from mycoplasma/acholeplasma species contamination by ELISA (Mycoplasma Detection kit; Roche) incorporating polyclonal Abs against M. arginini, M. hyorhinis, A. laidlawii, and M. orale. Highly pure (Ͼ95%) mature schizonts were harvested from cultures of 5-8% parasitaemia by adherence to a LD magnetic separation column (Miltenyi Biotec). Columns were washed thoroughly with PBS to remove uninfected erythrocytes before elution. Schizont iRBC or uninfected erythrocytes were added to cell cultures at a ratio of three RBC to mononuclear cell.
Mycobacterium bovis bacillus Calmette-Guérin (BCG, Pasteur strain) was a gift from U. E. Schaible (Research Center Borstel, Borstel, Germany) and was grown in Difco Middlebrook 7H9 Broth complemented with 0.05% polysorbate 80 (v/v) (BDH) and 10% (v/v) (BBL) oleic acid, bovine albumin, dextrose, and catalase (OADC; BD Biosciences). Bacteria were harvested at a density of 10 9 bacteria/ml, homogenized using a 23G syringe needle and added to the cells using a multiplicity of infection of 10:1.
LPS purified from Salmonella typhimurium (Sigma-Aldrich) was used at a concentration of 1 g/ml. Human recombinant IL-12, human recombinant IFN-␣ (PeproTech), and human recombinant IL-18 (MBL) were each used at 0.1 g/ml.
Cell surface and intracellular staining for flow cytometry
Surface and intracellular staining was performed as previously described (17) . The Abs used were: anti-CD3 PerCP, IgG1 PerCP, anti-KIR3DL1 (clone DX9), and anti-KIR2DL2/3 and KIR2DS2 (clone DX27; BD Biosciences); anti-CD56 allophycocyanin, IgG2a allophycocyanin (Beckman Coulter), anti-IFN-␥ FITC, IgG1 FITC (Serotec), and anti-KIR3DL1 (clone Z27), anti-KIR2DL1/S1 (clone EB6; Immunotech). Flow cytometric analyses were performed using a BD Biosciences FACSCalibur flow cytometer and FlowJo analysis software (Tree Star).
HLA class I and KIR genotyping
Genomic DNA was extracted from PBMC using the QIAamp DNA Blood Mini kit (Qiagen). Intermediary-resolution HLA-A, HLA-B, and HLA-C genotypes were determined by PCR sequence-specific oligonucleotide probes, using LABType SSO (One Lambda). Generic KIR typing was performed by PCR amplification of genomic DNA using primers targeted to regions specific for each KIR; two primer sets were used as described (21, 22) . Allele-specific KIR3DL1/S1 genotypes were determined by pyrosequencing (23) . The likely functional and nonfunctional alleles of KIR2DS4 were distinguished using allele-specific primers (24) . Normally expressed (10A) and truncated (9A) alleles of KIR2DL4 were distinguished using previously described primers (25) to generate amplicons for pyrosequencing. The number of expressible KIR genes present in each individual was calculated from their generic and allele-specific genotypes according to previously described haplotype segregation (24, 26) and by the 2DL4 and 3DL1/S1 copy numbers that were determined by pyrosequencing. KIR3DL1*004, 3DS1*049N, 2DL5B, and 2DS4*003-7 were counted as nonexpressed alleles.
Statistical analysis
All statistical analyses were performed using Prism 4 software (GraphPad).
Results
Both CD56 dim and CD56 bright NK cells produce IFN-␥ in response to cytokine and microbial stimulation
It is often assumed that CD56 bright NK cells constitute the major IFN-␥-secreting subset of NK cells and that CD56 dim NK cells primarily fulfill a cytotoxic function (10) . Challenging this dichotomy was our observation that P. falciparum iRBC induce significant IFN-␥ production by human CD56 dim NK cells (17 Fig. 2A) , and the mean fluorescence intensity for IFN-␥ staining was somewhat higher in CD56 bright than in CD56 dim NK cells (Fig. 2B) . However, as CD56 dim NK cells represent more than 90% of the NK cells in peripheral blood (see Supplemental Fig.  I ), 7 the vast majority (ϳ80%) of IFN-␥ ϩ peripheral blood NK cells are CD56 dim (Fig. 2C) . It is notable, however, that in contrast to the other stimuli, the mix of IL-18 plus IFN-␣ preferentially induces IFN-␥ production by CD56 dim rather than CD56 bright NK cells.
IFN-␥ production by CD56 dim and CD56 bright NK cells varies between donors
For some donors, CD56 dim and CD56 bright populations of NK cells responded similarly to microbial or cytokine stimuli (Fig.  1B) , whereas for other donors the IFN-␥ response of CD56 dim NK cells response appeared inhibited by comparison to the response of their CD56 bright cells (Fig. 1A) . To quantify this effect, we calculated the ratio between the percentage of CD56 dim NK cells and the percentage of CD56 bright producing IFN-␥ in response to each stimulus (Fig. 3A) . This ratio, which we have termed the "DIM factor," is a measure of the extent to which the CD56 dim NK cells of an individual respond to a particular stimulus when compared with their CD56 bright NK cells; a DIM factor ratio of less than 1 indicates that the CD56 dim NK cell population is relatively inhibited compared with the CD56 bright population.
We calculated the DIM factor for the response of NK cells of up to 40 donors to the various stimuli (Fig. 3B) (Fig. 3C) . Moreover, for an individual donor, DIM factors for NK cells stimulated with LPS, BCG, or iRBC were highly correlated with DIM factors for cells stimulated with IL-12 plus IL-18 (Fig. 4) . Similarly pairwise comparisons between DIM factors for any two microbial stimuli were highly correlated (R 2 Ն 0.89 for all comparisons). DIM factors for IL-18 plus IFN-␣-stimulated NK cells were significantly correlated with DIM factors for IL-12 plus IL-18; however, the correlation coefficient (R 2 ϭ 0.37) was lower than for other comparisons.
These analyses indicate that the relative response of CD56 dim and CD56 bright NK cells to different microbial stimuli is constant within an individual but varies within the human population.
Accessory cell signals and DIM factor independently regulate NK cell IFN-␥ responses to iRBC
Accessory cell-dependence is emerging as a general feature of NK cell responses to pathogens, the necessary cytokines including IL-12, IL-18, and IFN-␣ (2). We have previously shown that NK cell IFN-␥ responses to iRBC depend upon contact-dependent and cytokine-mediated signals from myeloid accessory cells (27) and that the magnitude of the NK IFN-␥ response (and especially of CD56 bright NK cells) is correlated with the magnitude of the accessory cell response (27) . To determine whether the DIM factor is a manifestation of the magnitude of the accessory cell response to iRBC, we compared the DIM factor with the amount of IL-12 secreted into the culture, but found no correlation (see Supplemental Fig. II) . 7 Thus, although the magnitude of the accessory cell response to pathogen-derived ligands influences the absolute magnitude of the NK cell IFN-␥ response (27) , the DIM factor appears to be independent of the accessory cell response.
We conclude that two independent factors determine the magnitude of the NK cell IFN-␥ response to microbial stimuli, namely the size of the accessory cell signal and the DIM factor. In Fig. 5 , data from three donors illustrate how these two factors interact to determine the overall NK response to iRBC. Donor 177 has both a high DIM factor (0.9) and high levels of accessory cell IL-12 secretion in response to iRBC. This combination leads to a potent NK cell response to iRBC in which 44% of the NK cells are induced to make IFN-␥. For donor 147 a moderate accessory cell 7 The online version of this article contains supplemental materials. (14) . In confirmation of this report, we analyzed KIR surface expression on NK cells from 12 donors using mAbs specific for four different groups of KIR (but not KIR2DL4) and found that 10 -50% of CD56 dim NK cells stained positively with each of the anti-KIR Abs, and that on average 55.7% of CD56 dim NK cells were labeled by a mix of all four KIR Abs, whereas few (Ͻ5%) CD56 bright NK cells stained with any of the Abs (see Supplemental Fig. III) . 7 We therefore considered the possibility that responses of KIR ϩ CD56 dim NK cells to microbial and cytokine stimulation might be regulated via KIR-MHC class I interactions.
KIR genotypes were determined for 81 individuals for whom the DIM factor was known and MHC class I genotypes were determined for 47 of these. KIR genotypes were compiled from KIR gene-specific and allele-specific typing and assigned as AA, AB, or BB according to those previously defined from haplotype segregation in families (21, 24, 26) . The number of expressible KIR genes present in each individual was calculated from their allelespecific genotypes and by the 2DL4 and 3DL1/S1 copy numbers determined by pyrosequencing. KIR3DL1*004, 3DS1*049N, 2DL5B, and 2DS4*003-7 were counted as nonexpressed alleles. Among our donor population, 27 (33%) were homozygous for A haplotypes, 17 (21%) were homozygous for B haplotypes, and 37 (46%) were AB heterozygotes.
DIM factor varied significantly with KIR genotype (Fig. 6 ). Cell donors were grouped according to whether they were KIR-A or KIR-B homozygotes or KIR-AB heterozygotes. The mean DIM factor did not differ between KIR-A homozygotes and KIR-B homozygotes (mean ϩ (SEM), 0.56 (0.04) and 0.58 (0.05), respectively), . Similarly, when donors were grouped by DIM factor (low, Ͻ0.5; medium, 0.5-0.7; high, Ͼ0.7) we observed that the proportion of AB individuals increased (and the proportion of AA individuals decreased) significantly with increasing DIM factor ( p ϭ 0.0007; data not shown).
No association was observed between DIM factor and the presence or absence of any particular KIR gene (see Supplemental Fig.  IV) , 7 the presence of any particular KIR-HLA ligand pair (see Supplemental Fig. V) 7 or the total number of different KIR genes in the genotype (data not shown).
Similarly, although one explanation for the low DIM factor (i.e., highly inhibited CD56 dim NK cells) in AA individuals might be that these individuals have a paucity of activating KIR (KIR2DS4 only) compared with AB and BB individuals, when we stratified our donor cohort by the total number of activating KIR in their genotype, there was no systematic association with DIM factor (see Supplemental Fig. VI.A) . 7 There was a trend for the DIM factor to be higher (i.e., for CD56 dim cells to respond more like CD56 bright cells) for individuals with more inhibitory KIR genes in their genotype; however, this response did not reach statistical significance (one-way ANOVA test for linear trend; p ϭ 0.07).
How does KIR genotype affect NK cell IFN-␥ responses?
We have considered two mechanisms by which KIR genotype might affect NK cell IFN-␥ responses. Firstly, signaling resulting from ongoing ligation of KIR (by HLA class I on accessory cells) during in vitro culture might modulate the degree of activation of NK cells by microbial or cytokine stimuli. Alternatively, binding of KIR (or other inhibitory receptors) by relevant MHC and MHClike ligands during NK cell ontogeny might lead to greater or lesser education (or licensing) of NK cells, in which case the degree to which CD56 dim NK cells are educated, relative to CD56 bright NK cells, would determine the DIM factor.
No evidence for in vitro HLA class I-mediated inhibition of KIR-positive NK cells
To investigate whether KIR-HLA interactions occurring in vitro modify NK cell activation we stimulated PBMC with IL-12 plus IL-18 for 24 h in the presence of blocking anti-HLA class I Abs (DX17 or W6/32) or an isotype-matched control Ab. As shown in Fig. 7 , A and B, both Abs bound efficiently to lymphocytes and monocytes and remained bound for the duration of the experiment, but neither Ab had any significant or consistent effect on NK cell IFN-␥ responses. These data indicate that interrupting KIR-HLA interactions in real time does not influence NK cell IFN-␥ production.
To explore this further, we examined the effect of a single KIR-HLA interaction on NK cell activation by comparing IFN-␥ responses in NK cells from six donors carrying at least one copy of KIR2DL1 (and no copies of KIR2DS1) when cultured in the presence of HLA class I-deficient 721.221 cells (18) lines expressed low and high levels of HLA-Cw6-GFP, respectively (Fig. 7C, first panel) . Purified NK cells were cultured in a 1:1 ratio with HLA class I-positive 721.221.6.2 or 721.221.6.4 cells, or with HLA class I-negative 721.221 cells, for 24 h in the presence or absence of IL-12 plus IL-18. In unstimulated cultures, at this NK to target cell ratio, there was no induction of IFN-␥ in NK cells whether the target cells expressed or did not express HLA-Cw6 (data not shown). Importantly, the presence or absence of cells expressing HLA-Cw6 made no consistent or significant difference to the proportion of either CD56 bright or CD56 dim NK cells making IFN-␥ in response to IL-12 plus IL-18 and consequently the DIM factor was unchanged (Fig. 7C, last three panels) . Thus, when NK cells and target cells are cultured together at an appropriate ratio and in the absence of any exogenous stimuli, the absence of KIR-MHC interactions does not cause NK cells to be activated to make IFN-␥; furthermore, the absence of MHC class I ligands does not influence their ability to respond to accessory cell-derived/pathogen-induced signals. Taken together, these two independent sets of experiments suggest that KIR-MHC interactions are not influencing NK responses to accessory cell-derived signals in real time.
Discussion
Understanding the means by which innate immune responses are regulated offers the possibility to design more effective adjuvants and anti-inflammatory agents and to better understand disease susceptibility. There is now a substantial body of evidence to suggest that KIR-HLA interactions influence susceptibility to viral infections and neoplasia (7, 8) presumably by regulating the ability of NK cells to lyse host cells that express abnormally low levels of self-MHC (29) . By comparison, very little is known regarding the role of KIR-HLA class I-mediated regulation of responses to classes of pathogens for which cytokine production rather than cytolysis is the more relevant effector response. bright and CD56 dim NK cells (i.e., the DIM factor) is associated with KIR genotype, providing the first direct evidence that KIR genotype may influence the NK response to a wide range of nonviral pathogens. Taking these findings together with our previous observation that the magnitude of the NK cell IFN-␥ response, and of the CD56 bright (KIRnegative) subset in particular, to iRBC is highly correlated with the degree of myeloid accessory cell activation (as assessed by upregulation of CD40 and HLA-DR as well as secretion of IL-12) (27) we propose that NK cell IFN-␥ responses to external pathogen-derived stimuli are regulated by (at least) two independent factors. One of these is the strength of the accessory cell (cytokine and or costimulatory molecule) signal and this affects all NK cells to the same degree. The other is the regulatory effect conferred by KIR gene expression. This differs between clones of NK cells (because they express slightly different combinations of KIR genes) and between individuals (because their KIR genotype differs). Because CD56 bright NK cells are essentially KIR-negative, their response is unaffected by the regulatory effects of KIRs and thus, for each donor, the response of the CD56 bright NK cell population is an indication of the strength of the accessory cell stimulus and represents the unregulated baseline NK response. However, the response of the CD56 dim (KIR-positive) subset depends upon both the strength of accessory cell signals and the degree to which this is regulated by KIR gene expression. Thus, the difference between the response of the CD56 bright and CD56 dim cells (the DIM factor) is an indication of the strength of the regulation imposed by the KIR genotype.
Whereas the KIR genotype effect is constant, resulting in DIM factors that are highly correlated for different ligands, accessory cell responses may vary from one pathogen to another depending on the affinity (and amount) of their ligands for the various pattern recognition receptors expressed on different accessory cell populations (2). Indeed, we provide direct evidence that the nature of the accessory cell signals can profoundly affect that NK response because, in combination with IL-18, IFN-␣ much more efficiently induces IFN-␥ production from CD56 dim NK cells than does IL-12. It is possible, therefore, that infections that induce high levels of IFN-␣ and IL-18 may induce particularly potent NK IFN-␥ responses. It is likely, however, that environmental factors, specifically prior or concurrent infections, might also contribute to the shaping of NK compartments, either by modifying the accessory cell stimulus or by modifying the frequency and functional maturity of specific NK cell subsets. In our study, such environmental factors may account for differences in NK cell responses between individuals with similar KIR genotypes.
The ability of NK cells to kill cells expressing abnormally low levels of MHC class I molecules is determined by their expression of inhibitory receptors for relevant MHC ligands during NK cell development: only NK cells that express appropriate receptors are "educated" (or "licensed") for subsequent cytotoxic activity (30, 31) . Whether education also affects NK cell capacity to respond to pathogen-derived signals is less clear, although educated NK cells have been shown to be more responsive (as judged by IFN-␥ production) to IL-12 plus IL-18 than uneducated NK cells (11, 32) . Conversely, it has been suggested that, in mouse cells at least, pathogen-induced signals can overcome the lack of licensing such that all NK cells, whatever their regulatory receptor phenotype, can respond to inflammatory signals (33) . Our data, however, provide convincing evidence that an individual's KIR genotype does in fact predict the capacity of their NK cells (or at least, the majority CD56 dim subset of NK cells) to produce IFN-␥ in response to numerous indirect stimuli.
Although NK cells have been reported to make IFN-␥ when cultured with HLA class I-deficient 721.221 tumor cells (34) we found no evidence that NK cells were induced to make IFN-␥ when cultured at a 1:1 ratio with 721.221 cells (in the absence of IL-2). Moreover, NK cells cultured with blocking Abs to MHC class I or with 721.221 cells were no more or less able to make IFN-␥ in response to IL-12 plus IL-18, a classical accessory cell stimulus for NK cells, than were NK cells cultured with MHC sufficient cells. Thus, because blocking ongoing KIR-HLA interactions during NK activation does not appear to influence IFN-␥ production, we suggest that KIR genotype may affect the NK cell at a much earlier stage of NK cell ontogeny; in other words, this may be an example of NK cell education.
Our data suggest that the overall KIR genotype, rather than any single KIR or KIR-HLA interaction, determines the responsiveness of KIR-positive NK cells. Indeed, our data appear to be a classical example of heterozygote advantage, with AB heterozygotes having the most educated NK cells. This idea is very much in line with the concept that NK cell activation depends upon integration of signals from numerous inhibitory and activating receptors; AB heterozygotes might be expected to express a wider range of KIR alleles than would AA or BB homozygotes and thus a greater proportion of their NK cells are likely to encounter an appropriate self-ligand and be licensed. Our data thus offer a mechanistic explanation for the observation that balancing selection has maintained an even frequency of A and B haplotypes (and a correspondingly high frequency of AB heterozygotes) in isolated Amazonian Amerindian populations (35) . However, we cannot formally rule out the possibility that specific KIR alleles determine responsiveness because one consequence of having a large number of KIR genes available for expression is that each KIR is likely to be expressed at a relatively low frequency, making it difficult to observe the effect of any one particular receptor.
Of interest, several clinical studies have observed associations between disease state and overall KIR genotype rather than with the presence, absence or allelic variation in any particular KIR gene. For example, individuals with AA KIR genotypes are reported to be relatively protected against chronic inflammatory diseases (36, 37) , our data suggest that this might be explained by these AA individuals having relatively inhibited innate IFN-␥ responses. Similarly, among long-term HIV-exposed subjects, AB individuals were significantly more likely than AA individuals to remain seronegative (38) , consistent with the notion that individuals with less inhibited CD56 dim cells may make more effective antiviral responses.
In summary, we have found that the ability of NK cells to respond to accessory cell-derived cytokines is markedly affected by KIR genotype. Because these cytokines are classically induced from accessory cells by microbial ligands and are essential for NK cells to respond to pathogens as diverse as malaria and mycobacteria (2), our data reveal a hitherto unsuspected influence of KIR genotype on the ability of NK cells to respond to nonviral infections. When taken together with our recent evidence for major differences in KIR genotype between populations living under differing levels of pathogen exposure (23) our data suggest that the ability of NK cells to respond appropriately to common bacterial or protozoal, as well as viral, pathogens may represent a major force that is driving evolution of the KIR locus and, conversely, that KIR genotype might be significant predictor of susceptibility or resistance to many common infections.
